Spero Therapeutics (SPRO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to -$2.3 million.
- Spero Therapeutics' Other Gross PP&E Adjustments rose 4247.5% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year increase of 4247.5%. This contributed to the annual value of -$1.7 million for FY2024, which is 3620.27% down from last year.
- Spero Therapeutics' Other Gross PP&E Adjustments amounted to -$2.3 million in Q3 2025, which was up 4247.5% from -$3.5 million recorded in Q2 2025.
- Spero Therapeutics' 5-year Other Gross PP&E Adjustments high stood at -$1.2 million for Q4 2023, and its period low was -$8.5 million during Q1 2021.
- Over the past 5 years, Spero Therapeutics' median Other Gross PP&E Adjustments value was -$4.8 million (recorded in 2024), while the average stood at -$5.0 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 5580.5% in 2021, then surged by 4350.0% in 2023.
- Spero Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$3.5 million in 2021, then skyrocketed by 37.73% to -$2.2 million in 2022, then skyrocketed by 43.5% to -$1.2 million in 2023, then tumbled by 36.2% to -$1.7 million in 2024, then plummeted by 35.91% to -$2.3 million in 2025.
- Its Other Gross PP&E Adjustments was -$2.3 million in Q3 2025, compared to -$3.5 million in Q2 2025 and -$3.7 million in Q1 2025.